A Plonowski
Overview
Explore the profile of A Plonowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Busto R, Schally A, Braczkowski R, Plonowski A, Krupa M, Groot K, et al.
Regul Pept
. 2002 Sep;
108(2-3):47-53.
PMID: 12220726
Splice variants (SV) of receptors for growth hormone-releasing hormone (GHRH) have been found in several human cancer cell lines. GHRH antagonists inhibit growth of various human cancers, including osteosarcomas and...
2.
SZEREDAY Z, Schally A, Nagy A, Plonowski A, Bajo A, Halmos G, et al.
Br J Cancer
. 2002 Apr;
86(8):1322-7.
PMID: 11953892
Some brain tumours, such as glioblastomas express high levels of receptors for bombesin/gastrin releasing peptide. We investigated whether bombesin/gastrin releasing peptide receptors found in glioblastoma cell lines can be utilised...
3.
Schally A, Comaru-Schally A, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, et al.
Front Neuroendocrinol
. 2001 Oct;
22(4):248-91.
PMID: 11587553
The use of peptide analogs for the therapy of various cancers is reviewed. Inhibition of the pituitary-gonadal axis forms the basis for oncological applications of luteinizing hormone-releasing hormone (LH-RH) agonists...
4.
Plonowski A, Schally A, Koppan M, Nagy A, Arencibia J, Csernus B, et al.
Cancer
. 2001 Sep;
92(5):1168-76.
PMID: 11571730
Background: Cytotoxic analogs of somatostatin (SST), such as AN-238, which consists of 2-pyrrolinodoxorubicin (AN-201) linked to the SST carrier RC-121, can be targeted to tumors that express SST receptors. Because...
5.
Rekasi Z, Schally A, Plonowski A, Czompoly T, Csernus B, Varga J
Prostate
. 2001 Aug;
48(3):188-99.
PMID: 11494334
Background: Prostate-specific antigen (PSA) is the best tumor marker for diagnosis and prognosis of prostatic carcinoma. The secretion of PSA from LNCaP human prostate cancer cells is influenced by acute...
6.
Arencibia J, Schally A, Krupa M, Bajo A, Nagy A, Szepeshazi K, et al.
Int J Oncol
. 2001 Aug;
19(3):571-7.
PMID: 11494038
Receptors for luteinizing hormone-releasing hormone (LHRH), expressed by ovarian cancers, can be used for targeting chemotherapeutic compounds more selectively to these tumors. We investigated the effects of cytotoxic LHRH analog...
7.
Rekasi Z, Varga J, Schally A, Plonowski A, Halmos G, Csernus B, et al.
Peptides
. 2001 Jun;
22(6):879-86.
PMID: 11390017
We evaluated the effects of GHRH antagonists on the proliferation of MiaPaCa-2 human pancreatic cancer cells and cAMP signaling in vitro. GHRH antagonists inhibited the proliferation of MiaPaCa-2 cells in...
8.
Plonowski A, Nagy A, Schally A, Sun B, Groot K, Halmos G
Int J Cancer
. 2000 Nov;
88(4):652-7.
PMID: 11058885
The effectiveness of chemotherapy targeted to bombesin (BN) receptors was evaluated in nude mice bearing PC-3 human androgen-independent prostate cancers. Cytotoxic BN analogue AN-215, consisting of 2-pyrrolinodoxorubicin (AN-201) linked to...
9.
Schally A, Comaru-Schally A, Plonowski A, Nagy A, Halmos G, Rekasi Z
Prostate
. 2000 Oct;
45(2):158-66.
PMID: 11027415
The use of peptide analogs in the therapy of prostate cancer is reviewed. The preferred primary treatment of advanced androgen-dependent prostate cancer is presently based on the use of depot...
10.
Halmos G, Schally A, Varga J, Plonowski A, Rekasi Z, Czompoly T
Proc Natl Acad Sci U S A
. 2000 Aug;
97(19):10555-60.
PMID: 10962030
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the proliferation of various human cancers in vitro and in vivo by mechanisms that include apparent direct effects through specific binding sites expressed...